Arrhythmia Disorders

Top Story

TNT-POAF: Botulinum toxin may reduce postoperative AF

November 15, 2017

Read the Perspective from Renate B. Schnabel, MD, MSc

ANAHEIM, Calif. — Epicardial fat pad injections of botulinum toxin may be a safe way to reduce postoperative atrial fibrillation without increasing adverse events after cardiac surgery, according to the results of the TNT-POAF study presented at the American Heart Association Scientific Sessions.

Postoperative AF is the most common complication after cardiac surgery and is unfortunately one that is associated with postoperative morbidity, increased length of stay in the ICU in the hospital and short and long-term mortality,” Nathan H. Waldron, MD, MHSc, from Duke University Medical Center, said during his presentation. “Cardiac autonomic dysregulation has consistently been linked with the development of AF and the clinical strategies to modulate the intrinsic cardiac autonomous nervous system met some preliminary success in reducing AF.”

Meeting NewsPerspective

ABRIDGE-J: Dabigatran lowers bleeding risk in ablation for nonvalvular AF

November 14, 2017
ANAHEIM, Calif. — Patients with nonvalvular atrial fibrillation who underwent ablation and were treated with minimally disrupted dabigatran with and without…
In the JournalsPerspective

Dabigatran safe, effective alternative to warfarin for AF

November 14, 2017
Compared with warfarin, dabigatran was associated with similar incidence of ischemic stroke and overall bleeding in patients with atrial fibrillation, according to data…
Meeting NewsPerspective

Diabetes in young adults, children drastically increases risk for sudden cardiac death

November 13, 2017
ANAHEIM, Calif. — Young adults and children with type 1 or type 2 diabetes have a greater risk for all-cause mortality and sudden cardiac death compared with their…
More Headlines »
CME CNE CPE

Integrating New Options Into Guideline-Directed Management of Heart Failure with Reduced Ejection Fraction

This activity is supported by educational funding provided by Amgen, Novartis Pharmaceuticals Corporation and St. Jude Medical, Inc.

Heart failure (HF) is a chronic condition that requires long-term commitment on the part of the patient in adhering to…
More »
Video
Meeting News

VIDEO: PIONEER AF-PCI results may not translate to clinical practice

November 23, 2016
More »
Resource Centers
American Heart Association Scientific Sessions

American Heart Association Scientific Sessions

Video
Meeting News

VIDEO: Early intervention might provide clinical benefit in patients with high-risk non-STEMI

January 10, 2017
More »
Advertisement
Advertisement